African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 4939

Full Length Research Paper

Lactobacillus acidophilus and Bifidobacteria spp having antibacterial and antiviral effects on chronic HCV infection

Nanis G. Allam
  • Nanis G. Allam
  • Department of Botany, Microbiology Section, Faculty of Science, Tanta University, Egypt.
  • Google Scholar
Mohamed L. Salem
  • Mohamed L. Salem
  • Department of Zoology, Immunology and Biotechnology Unit, Faculty of Science, Center of Excellence in Cancer Research Tanta University, Egypt.
  • Google Scholar
Hassan Elbatae
  • Hassan Elbatae
  • Hepatology, Tropical Diseases Medicine, Kafr Elsheikh University, Egypt.
  • Google Scholar
Maii Moustafa Nabieh
  • Maii Moustafa Nabieh
  • Department of Botany, Microbiology Section, Faculty of Science, Tanta University, Egypt.
  • Google Scholar


  •  Received: 25 November 2018
  •  Accepted: 11 January 2019
  •  Published: 07 February 2019

References

Bali V, Panesar PS, Bera MB (2011). Isolation, screening and evaluation of antimicrobial activity of potential bacteriocin producing lactic acid bacteria isolate. Microbiology Journal 1: 113-119.
Crossref

 

Barry AL (1979). Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test. Journal of Clinical Microbiology 10(6):885-889.

 
 

Bermudez-Brito M, Plaza-Díaz J, Mu-oz-Quezada S, Gómez-Llorente C, Gil A (2012). Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61(2):160-174.
Crossref

 
 

Bièche I, Olivi M, Champème MH, Vidaud D, Lidereau R, Vidaud M (1998). Novel approach to quantitative polymerase chain reaction using realā€time detection: application to the detection of gene amplification in breast cancer. International Journal of Cancer 78(5):661-666.
Crossref

 
 

Bischoff G, Barbara G, Buurman W, Ockhuizen T, Schulzke D, Serino M, Tilg H, Watson A, Wells M (2014). Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterology 14:189.
Crossref

 
 

Blaising J, Pécheur EI (2013). "Lipids A Key for Hepatitis C Virus Entry and a Potential Target for Antiviral Strategies." Biochimie. 10.1016/j.biochi.2012.07.016.
Crossref

 
 

Butel MJ (2014). Probiotics, Gut Microbiota and Health. Medecine et Maladies Infectieuses 44(1):1-8
Crossref

 
 

Camus G, Herker E, Modi AA, Haas JT, Ramage HR, Farese RV, Ott M (2013). Diacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core. Journal of Biological Chemistry 288(14):9915-9923.
Crossref

 
 

Candore G, Balistreri CR, Colonna-Romano G, Grimaldi MP, Lio D, Listi' F, Scola L, Vasto S, Caruso C (2008). Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Research 11(2):425-432.
Crossref

 
 

Carrion JA, Martinez-Bauer E, Crespo G, Ramirez S, Perez-del-Pulgar S, Garcia-Valdecasas JC, Navasa M, Forns X (2009). Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study. Journal of Hepatology 50(4):719-728.
Crossref

 
 

Chen SL, Morgan TR (2006). The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 3(2):47-52.
Crossref

 
 

CLSI (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement, M100-S22.

 
 

Deye N, Vincent F, Michel P, Ehrmann S, Da Silva D, Piagnerelli M, Kimmoun A, Hamzaoui O, Lacherade JC, de Jonghe B, Brouard F (2016). Changes in cardiac arrest patients' temperature management after the 2013 "TTM" trial: results from an international survey. Annals of Intensive Care 6(1):4.
Crossref

 
 

Dore GJ, Ward J, Thursz M (2014). Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward). Journal of Viral Hepatitis 21 Suppl 1:1-4.

 
 

Doskali M, Tanaka Y, Ohira M, Ishiyama K, Tashiro H, Chayama K, Ohdan H (2011). Possibility of adoptive immunotherapy with peripheral blood-derived CD3−CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity. Journal of Immunotherapy 34(2):129-138.
Crossref

 
 

Degnan FH (2008). The US Food and Drug Administration and probiotics: regulatory categorization. Clinical Infectious Diseases 46 Suppl 2:S133-136.
Crossref

 
 

Funke G (1998). Evaluation of the VITEK 2 system for the rapid identification of medically relevant Gram-negative rods. Journal of Clinical Microbiology 36(7):1948-1952.

 
 

Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, Hindes RG, Berrey MM (2013). Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. The New England Journal of Medicine 368(1):34-44.
Crossref

 
 

Givan AL (2011). Flow cytometry: an introduction. Methods in Molecular Biology 699:1-29
Crossref

 
 

Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC (2013). Probiotics for the Prevention of Clostridium Difficile-Associated Diarrhea in Adults and Children. Cochrane Database of Systematic Reviews.
Crossref

 
 

Gratz SW, Mykkanen H, El-Nezami HS (2010). Probiotics and gut health: A special focus on liver diseases. World Journal of Gastroenterology 16(4):403-410.
Crossref

 
 

Harris CA, Haas JT, Streeper RS, Stone SJ, Kumari M, Yang K, Han X, Brownell N, Gross RW, Zechner R, Farese RV (2011). DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. Journal of Lipid Research 52(4):657-667.
Crossref

 
 

Hart A, Stagg A, Lammers K, Rizzello F, Gionchetti P, Campieri M, Knight S, Kamm M (2003). Probiotic Bacteria induce maturation and modulate cytokine production by human dendritic cells. Digestive Disease Week Abstracts and Itinerary Planner 2003:1246.
Crossref

 
 

Heathcote J, Main J (2005). Treatment of hepatitis C. Journal of Viral Hepatitis 12(3):223-235.
Crossref

 
 

Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, Farese Jr RV, Ott M (2010). Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nature Medicine 16(11):1295-1298.
Crossref

 
 

Hor YY, Liong MT (2014). Use of extracellular extracts of lactic acid bacteria and bifidobacteria for the inhibition of dermatological pathogen Staphylococcus aureus. Dermatologica Sinica pp. 1-7.
Crossref

 
 

Hung YH, Carreiro AL, Buhman KK (2017). Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1862(6):600-614.

 
 

Hütt P (2006). Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. Journal of Applied Microbiology 100(6):1324-1332.
Crossref

 
 

Ibrahim F, Ruvio S, Granlund L, Salminen S, Viitanen M, Ouwehand AC (2010). Probiotics and immunosenescence: cheese as a carrier. FEMS Immunology and Medical Microbiology 59(1):53-59.
Crossref

 
 

Imran ZK, Abd Al-Karrem Z (2016). Evaluation of natural cloning of azole-resistant genes CDR1, CDR2, MDR and ERG11 between clinical and soil isolates of Candida albicans based on gene expression. International Journal of PharmTech Research 9(11):229-236.

 
 

Jacobs DM, Gaudier E, Duynhoven JV, Vaughan EE (2009). Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Current Drug Metabolism 10(1):41-54.
Crossref

 
 

Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A (2014). Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference (2013). Journal of Hepatology 60(6):1310-1324.
Crossref

 
 

Kawano A, Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Dohmen K, Nomura H, Takahashi K, Satoh T, Azuma K, Tanabe Y (2015). Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection. Internal Medicine 54(6):567-572.
Crossref

 
 

Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, Fakiri EM (2013). Health benefits of probiotics: a review. ISRN Nutrition 2013:481651.
Crossref

 
 

Koch FE (1942). Mannitol salt agar (MSA) Zentr. Bakt. Labt. Orig.; 149:122.

 
 

Kim JY, Choi YO, Ji GE (2008). Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. Journal of Microbiology and Biotechnology 18(8):1393-1400.

 
 

Lam B, Henry L, Younossi Z (2014). Sofosbuvir (Sovaldi) for the treatment of hepatitis C. Expert Review of Clinical Pharmacology 7(5):555-566.
Crossref

 
 

Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST (2013). Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 57(4):1333-1342.
Crossref

 
 

Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez- Humarán LG (2013). Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microbial Cell Factories 12:71.
Crossref

 
 

Rask C, Adlerberth I, Berggren A., Ahren IL, Wold AE (2013). Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli. Clin Exp Immunol 172(2):321-332
Crossref

 
 

Reis JA, Paula AT, Casarotti SN, Penna ALB (2012). Lactic acid bacteria antimicrobial compounds: Characteristics and applications. Food Engineering Reviews 4:124-140.
Crossref

 
 

Swanson L (2013). How long does it take for Probiotics to Work? Long term benefits of probiotics, probiotic 101. https://probiotics101.probacto.com/how-long-does-it-take-for-probiotics-to-work/

 
 

Stagg AJ, Hart AL, Knight SC, Kamm MA (2004). "Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity." Best Practice and Research Clinical Gastroenterology 18(2):255-270.
Crossref

 
 

Stackebrandt E, Liesack W, Witt D, (1992). Ribosomal RNA and rDNA sequence analyses. Gene 115(1-2):255-260.
Crossref

 
 

Sikorska H, Smoragiewicz W (2013). Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. International Journal of Antimicrobial Agents 42(6):475-481.
Crossref

 
 

Servin AL (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews 28(4):405-440.
Crossref

 
 

Snydman DR (2008). The safety of probiotics. Clinical Infectious Diseases 46(Supplement_2):S104-S111.

 
 

Takeda S, Kawahara S, HIDAKA M, Yoshida H, Watanabe W, Takeshita M, Kikuchi Y, Bumbein D, Muguruma M, Kurokawa M (2013). Effects of oral administration of probiotics from Mongolian dairy products on the Th1 immune response in mice. Bioscience, Biotechnology and Biochemistry 77(7):1372-1378.
Crossref

 
 

Tsai YT, Cheng PC, Pan TM (2012). The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96(4):853-862
Crossref

 
 

Thomas CJ, McMeekin TA, Balis C (1977). Retention of bacteria in liquid films at agar surfaces. Applied and Environmental Microbiology 34(4).

 
 

Villamil L, Tafalla C, Figueras A, Novoa B (2002). Evaluation of immunomodulatory effects of lactic acid bacteria in turbot (Scophthalmus maximus). Clinical and Diagnostic Laboratory Immunology 9(6):1318-1323.

 
 

Yuan Q, Walker WA (2004). Innate immunity of the gut: mucosal defense in health and disease. Journal of Pediatric Gastroenterology and Nutrition 38(5):463-473.
Crossref

 
 

Ye L (2009). CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 49(3):753-762.
Crossref